Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Protalix BioTherapeutics, Inc. (PLX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Protalix BioTherapeutics, Inc. (PLX), most recent 12 months reported: revenue $80.62M, net income $18.95M, free cash flow $7.67M. Latest balance sheet on file: liquid cash $27.42M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): GINKGO BIOWORKS HOLDINGS, INC. · Century Therapeutics, Inc. · KYMERA THERAPEUTICS, INC. · 4D Molecular Therapeutics, Inc. · COMPUGEN LTD · CHAMPIONS ONCOLOGY, INC. · FENNEC PHARMACEUTICALS INC. · INVIVYD, INC.

Stock screener

Watchlist